equityflowunderstand the flow and follow it
EquityFlow › Companies › Orbis Medicines

Orbis Medicines

Biotech · Copenhagen, DK

Oral macrocycle drug discovery platform

In the network

Shares the most investors with (number = shared investors):
Precirix 2

Funding history

DateRoundAmount
Mar 2024Seed
Copenhagen biotech Orbis Medicines raised EUR 26M in seed financing led by Novo Holdings and Forbion for oral macrocycle drug discovery.
$28.1M

Investors

Tap an investor to see what else they have backed.

ForbionNovo Holdings

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in DK

ReelEveryday^LeafBlinkTrollGetWhySNIPR BiomeJoe & the JuiceHymethVentriJectGrand PMSDropla TechCellugy

Other companies at Seed stage

&Open(Re)vive1-2-Taste100% Livre1000 Satellites100ms10club10pct.10x Science10x.team123Projetei150 Minuten
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.